Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: QYResearch | PRODUCT CODE: 1257604

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1257604

Global Nuclear Molecular Imaging System Market Insights, Forecast to 2029

PUBLISHED:
PAGES: 113 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7350
PDF (Enterprise User License)
USD 9800

Add to Cart

This research report focuses on the Nuclear Molecular Imaging System Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Nuclear Molecular Imaging System Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Nuclear Molecular Imaging System Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Positron Emission Tomography
    • 1.2.3 Single-photon Emission Computed Tomography
    • 1.2.4 Planar Scintigraphy Systems
  • 1.3 Market by Application
    • 1.3.1 Global Nuclear Molecular Imaging System Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Oncology
    • 1.3.3 Cardiology
    • 1.3.4 Neurology
    • 1.3.5 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Executive Summary

  • 2.1 Global Nuclear Molecular Imaging System Sales Estimates and Forecasts 2018-2029
  • 2.2 Global Nuclear Molecular Imaging System Revenue by Region
    • 2.2.1 Global Nuclear Molecular Imaging System Revenue by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Global Nuclear Molecular Imaging System Revenue by Region (2018-2023)
    • 2.2.3 Global Nuclear Molecular Imaging System Revenue by Region (2024-2029)
    • 2.2.4 Global Nuclear Molecular Imaging System Revenue Market Share by Region (2018-2029)
  • 2.3 Global Nuclear Molecular Imaging System Sales Estimates and Forecasts 2018-2029
  • 2.4 Global Nuclear Molecular Imaging System Sales by Region
    • 2.4.1 Global Nuclear Molecular Imaging System Sales by Region: 2018 VS 2022 VS 2029
    • 2.4.2 Global Nuclear Molecular Imaging System Sales by Region (2018-2023)
    • 2.4.3 Global Nuclear Molecular Imaging System Sales by Region (2024-2029)
    • 2.4.4 Global Nuclear Molecular Imaging System Sales Market Share by Region (2018-2029)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

  • 3.1 Global Nuclear Molecular Imaging System Sales by Manufacturers
    • 3.1.1 Global Nuclear Molecular Imaging System Sales by Manufacturers (2018-2023)
    • 3.1.2 Global Nuclear Molecular Imaging System Sales Market Share by Manufacturers (2018-2023)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nuclear Molecular Imaging System in 2022
  • 3.2 Global Nuclear Molecular Imaging System Revenue by Manufacturers
    • 3.2.1 Global Nuclear Molecular Imaging System Revenue by Manufacturers (2018-2023)
    • 3.2.2 Global Nuclear Molecular Imaging System Revenue Market Share by Manufacturers (2018-2023)
    • 3.2.3 Global Top 10 and Top 5 Companies by Nuclear Molecular Imaging System Revenue in 2022
  • 3.3 Global Key Players of Nuclear Molecular Imaging System, Industry Ranking, 2021 VS 2022 VS 2023
  • 3.4 Global Nuclear Molecular Imaging System Sales Price by Manufacturers
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global Nuclear Molecular Imaging System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of Nuclear Molecular Imaging System, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of Nuclear Molecular Imaging System, Product Offered and Application
  • 3.8 Global Key Manufacturers of Nuclear Molecular Imaging System, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Nuclear Molecular Imaging System Sales by Type
    • 4.1.1 Global Nuclear Molecular Imaging System Historical Sales by Type (2018-2023)
    • 4.1.2 Global Nuclear Molecular Imaging System Forecasted Sales by Type (2024-2029)
    • 4.1.3 Global Nuclear Molecular Imaging System Sales Market Share by Type (2018-2029)
  • 4.2 Global Nuclear Molecular Imaging System Revenue by Type
    • 4.2.1 Global Nuclear Molecular Imaging System Historical Revenue by Type (2018-2023)
    • 4.2.2 Global Nuclear Molecular Imaging System Forecasted Revenue by Type (2024-2029)
    • 4.2.3 Global Nuclear Molecular Imaging System Revenue Market Share by Type (2018-2029)
  • 4.3 Global Nuclear Molecular Imaging System Price by Type
    • 4.3.1 Global Nuclear Molecular Imaging System Price by Type (2018-2023)
    • 4.3.2 Global Nuclear Molecular Imaging System Price Forecast by Type (2024-2029)

5 Market Size by Application

  • 5.1 Global Nuclear Molecular Imaging System Sales by Application
    • 5.1.1 Global Nuclear Molecular Imaging System Historical Sales by Application (2018-2023)
    • 5.1.2 Global Nuclear Molecular Imaging System Forecasted Sales by Application (2024-2029)
    • 5.1.3 Global Nuclear Molecular Imaging System Sales Market Share by Application (2018-2029)
  • 5.2 Global Nuclear Molecular Imaging System Revenue by Application
    • 5.2.1 Global Nuclear Molecular Imaging System Historical Revenue by Application (2018-2023)
    • 5.2.2 Global Nuclear Molecular Imaging System Forecasted Revenue by Application (2024-2029)
    • 5.2.3 Global Nuclear Molecular Imaging System Revenue Market Share by Application (2018-2029)
  • 5.3 Global Nuclear Molecular Imaging System Price by Application
    • 5.3.1 Global Nuclear Molecular Imaging System Price by Application (2018-2023)
    • 5.3.2 Global Nuclear Molecular Imaging System Price Forecast by Application (2024-2029)

6 US & Canada

  • 6.1 US & Canada Nuclear Molecular Imaging System Market Size by Type
    • 6.1.1 US & Canada Nuclear Molecular Imaging System Sales by Type (2018-2029)
    • 6.1.2 US & Canada Nuclear Molecular Imaging System Revenue by Type (2018-2029)
  • 6.2 US & Canada Nuclear Molecular Imaging System Market Size by Application
    • 6.2.1 US & Canada Nuclear Molecular Imaging System Sales by Application (2018-2029)
    • 6.2.2 US & Canada Nuclear Molecular Imaging System Revenue by Application (2018-2029)
  • 6.3 US & Canada Nuclear Molecular Imaging System Market Size by Country
    • 6.3.1 US & Canada Nuclear Molecular Imaging System Revenue by Country: 2018 VS 2022 VS 2029
    • 6.3.2 US & Canada Nuclear Molecular Imaging System Sales by Country (2018-2029)
    • 6.3.3 US & Canada Nuclear Molecular Imaging System Revenue by Country (2018-2029)
    • 6.3.4 US
    • 6.3.5 Canada

7 Europe

  • 7.1 Europe Nuclear Molecular Imaging System Market Size by Type
    • 7.1.1 Europe Nuclear Molecular Imaging System Sales by Type (2018-2029)
    • 7.1.2 Europe Nuclear Molecular Imaging System Revenue by Type (2018-2029)
  • 7.2 Europe Nuclear Molecular Imaging System Market Size by Application
    • 7.2.1 Europe Nuclear Molecular Imaging System Sales by Application (2018-2029)
    • 7.2.2 Europe Nuclear Molecular Imaging System Revenue by Application (2018-2029)
  • 7.3 Europe Nuclear Molecular Imaging System Market Size by Country
    • 7.3.1 Europe Nuclear Molecular Imaging System Revenue by Country: 2018 VS 2022 VS 2029
    • 7.3.2 Europe Nuclear Molecular Imaging System Sales by Country (2018-2029)
    • 7.3.3 Europe Nuclear Molecular Imaging System Revenue by Country (2018-2029)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Russia

8 China

  • 8.1 China Nuclear Molecular Imaging System Market Size
    • 8.1.1 China Nuclear Molecular Imaging System Sales (2018-2029)
    • 8.1.2 China Nuclear Molecular Imaging System Revenue (2018-2029)
  • 8.2 China Nuclear Molecular Imaging System Market Size by Application
    • 8.2.1 China Nuclear Molecular Imaging System Sales by Application (2018-2029)
    • 8.2.2 China Nuclear Molecular Imaging System Revenue by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Nuclear Molecular Imaging System Market Size by Type
    • 9.1.1 Asia Nuclear Molecular Imaging System Sales by Type (2018-2029)
    • 9.1.2 Asia Nuclear Molecular Imaging System Revenue by Type (2018-2029)
  • 9.2 Asia Nuclear Molecular Imaging System Market Size by Application
    • 9.2.1 Asia Nuclear Molecular Imaging System Sales by Application (2018-2029)
    • 9.2.2 Asia Nuclear Molecular Imaging System Revenue by Application (2018-2029)
  • 9.3 Asia Nuclear Molecular Imaging System Sales by Region
    • 9.3.1 Asia Nuclear Molecular Imaging System Revenue by Region: 2018 VS 2022 VS 2029
    • 9.3.2 Asia Nuclear Molecular Imaging System Revenue by Region (2018-2029)
    • 9.3.3 Asia Nuclear Molecular Imaging System Sales by Region (2018-2029)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 China Taiwan
    • 9.3.7 Southeast Asia
    • 9.3.8 India

10 Middle East, Africa and Latin America

  • 10.1 Middle East, Africa and Latin America Nuclear Molecular Imaging System Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America Nuclear Molecular Imaging System Sales by Type (2018-2029)
    • 10.1.2 Middle East, Africa and Latin America Nuclear Molecular Imaging System Revenue by Type (2018-2029)
  • 10.2 Middle East, Africa and Latin America Nuclear Molecular Imaging System Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America Nuclear Molecular Imaging System Sales by Application (2018-2029)
    • 10.2.2 Middle East, Africa and Latin America Nuclear Molecular Imaging System Revenue by Application (2018-2029)
  • 10.3 Middle East, Africa and Latin America Nuclear Molecular Imaging System Sales by Country
    • 10.3.1 Middle East, Africa and Latin America Nuclear Molecular Imaging System Revenue by Country: 2018 VS 2022 VS 2029
    • 10.3.2 Middle East, Africa and Latin America Nuclear Molecular Imaging System Revenue by Country (2018-2029)
    • 10.3.3 Middle East, Africa and Latin America Nuclear Molecular Imaging System Sales by Country (2018-2029)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Turkey
    • 10.3.7 Israel
    • 10.3.8 GCC Countries

11 Company Profiles

  • 11.1 Bruker
    • 11.1.1 Bruker Company Information
    • 11.1.2 Bruker Overview
    • 11.1.3 Bruker Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.1.4 Bruker Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Bruker Recent Developments
  • 11.2 GE Healthcare
    • 11.2.1 GE Healthcare Company Information
    • 11.2.2 GE Healthcare Overview
    • 11.2.3 GE Healthcare Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.2.4 GE Healthcare Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 GE Healthcare Recent Developments
  • 11.3 Siemens Healthcare
    • 11.3.1 Siemens Healthcare Company Information
    • 11.3.2 Siemens Healthcare Overview
    • 11.3.3 Siemens Healthcare Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.3.4 Siemens Healthcare Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Siemens Healthcare Recent Developments
  • 11.4 Philips Healthcare
    • 11.4.1 Philips Healthcare Company Information
    • 11.4.2 Philips Healthcare Overview
    • 11.4.3 Philips Healthcare Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.4.4 Philips Healthcare Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Philips Healthcare Recent Developments
  • 11.5 Canon Medical Systems
    • 11.5.1 Canon Medical Systems Company Information
    • 11.5.2 Canon Medical Systems Overview
    • 11.5.3 Canon Medical Systems Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.5.4 Canon Medical Systems Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Canon Medical Systems Recent Developments
  • 11.6 Hitachi Medical
    • 11.6.1 Hitachi Medical Company Information
    • 11.6.2 Hitachi Medical Overview
    • 11.6.3 Hitachi Medical Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.6.4 Hitachi Medical Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Hitachi Medical Recent Developments
  • 11.7 Digirad Corporation
    • 11.7.1 Digirad Corporation Company Information
    • 11.7.2 Digirad Corporation Overview
    • 11.7.3 Digirad Corporation Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.7.4 Digirad Corporation Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Digirad Corporation Recent Developments
  • 11.8 DDD-Diagnostics A/S
    • 11.8.1 DDD-Diagnostics A/S Company Information
    • 11.8.2 DDD-Diagnostics A/S Overview
    • 11.8.3 DDD-Diagnostics A/S Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.8.4 DDD-Diagnostics A/S Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 DDD-Diagnostics A/S Recent Developments
  • 11.9 Neusoft Medical Systems Co. Ltd.
    • 11.9.1 Neusoft Medical Systems Co. Ltd. Company Information
    • 11.9.2 Neusoft Medical Systems Co. Ltd. Overview
    • 11.9.3 Neusoft Medical Systems Co. Ltd. Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.9.4 Neusoft Medical Systems Co. Ltd. Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 Neusoft Medical Systems Co. Ltd. Recent Developments
  • 11.10 Mediso Medical Imaging Systems, Ltd.
    • 11.10.1 Mediso Medical Imaging Systems, Ltd. Company Information
    • 11.10.2 Mediso Medical Imaging Systems, Ltd. Overview
    • 11.10.3 Mediso Medical Imaging Systems, Ltd. Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.10.4 Mediso Medical Imaging Systems, Ltd. Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Mediso Medical Imaging Systems, Ltd. Recent Developments
  • 11.11 SurgicEye GmbH
    • 11.11.1 SurgicEye GmbH Company Information
    • 11.11.2 SurgicEye GmbH Overview
    • 11.11.3 SurgicEye GmbH Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.11.4 SurgicEye GmbH Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.11.5 SurgicEye GmbH Recent Developments
  • 11.12 CMR Naviscan Corporation
    • 11.12.1 CMR Naviscan Corporation Company Information
    • 11.12.2 CMR Naviscan Corporation Overview
    • 11.12.3 CMR Naviscan Corporation Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.12.4 CMR Naviscan Corporation Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.12.5 CMR Naviscan Corporation Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Nuclear Molecular Imaging System Industry Chain Analysis
  • 12.2 Nuclear Molecular Imaging System Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Nuclear Molecular Imaging System Production Mode & Process
  • 12.4 Nuclear Molecular Imaging System Sales and Marketing
    • 12.4.1 Nuclear Molecular Imaging System Sales Channels
    • 12.4.2 Nuclear Molecular Imaging System Distributors
  • 12.5 Nuclear Molecular Imaging System Customers

13 Market Dynamics

  • 13.1 Nuclear Molecular Imaging System Industry Trends
  • 13.2 Nuclear Molecular Imaging System Market Drivers
  • 13.3 Nuclear Molecular Imaging System Market Challenges
  • 13.4 Nuclear Molecular Imaging System Market Restraints

14 Key Findings in The Global Nuclear Molecular Imaging System Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Nuclear Molecular Imaging System Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Nuclear Molecular Imaging System Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Positron Emission Tomography
    • 1.2.3 Single-photon Emission Computed Tomography
    • 1.2.4 Planar Scintigraphy Systems
  • 1.3 Market by Application
    • 1.3.1 Global Nuclear Molecular Imaging System Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Oncology
    • 1.3.3 Cardiology
    • 1.3.4 Neurology
    • 1.3.5 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Executive Summary

  • 2.1 Global Nuclear Molecular Imaging System Sales Estimates and Forecasts 2018-2029
  • 2.2 Global Nuclear Molecular Imaging System Revenue by Region
    • 2.2.1 Global Nuclear Molecular Imaging System Revenue by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Global Nuclear Molecular Imaging System Revenue by Region (2018-2023)
    • 2.2.3 Global Nuclear Molecular Imaging System Revenue by Region (2024-2029)
    • 2.2.4 Global Nuclear Molecular Imaging System Revenue Market Share by Region (2018-2029)
  • 2.3 Global Nuclear Molecular Imaging System Sales Estimates and Forecasts 2018-2029
  • 2.4 Global Nuclear Molecular Imaging System Sales by Region
    • 2.4.1 Global Nuclear Molecular Imaging System Sales by Region: 2018 VS 2022 VS 2029
    • 2.4.2 Global Nuclear Molecular Imaging System Sales by Region (2018-2023)
    • 2.4.3 Global Nuclear Molecular Imaging System Sales by Region (2024-2029)
    • 2.4.4 Global Nuclear Molecular Imaging System Sales Market Share by Region (2018-2029)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

  • 3.1 Global Nuclear Molecular Imaging System Sales by Manufacturers
    • 3.1.1 Global Nuclear Molecular Imaging System Sales by Manufacturers (2018-2023)
    • 3.1.2 Global Nuclear Molecular Imaging System Sales Market Share by Manufacturers (2018-2023)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nuclear Molecular Imaging System in 2022
  • 3.2 Global Nuclear Molecular Imaging System Revenue by Manufacturers
    • 3.2.1 Global Nuclear Molecular Imaging System Revenue by Manufacturers (2018-2023)
    • 3.2.2 Global Nuclear Molecular Imaging System Revenue Market Share by Manufacturers (2018-2023)
    • 3.2.3 Global Top 10 and Top 5 Companies by Nuclear Molecular Imaging System Revenue in 2022
  • 3.3 Global Key Players of Nuclear Molecular Imaging System, Industry Ranking, 2021 VS 2022 VS 2023
  • 3.4 Global Nuclear Molecular Imaging System Sales Price by Manufacturers
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global Nuclear Molecular Imaging System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of Nuclear Molecular Imaging System, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of Nuclear Molecular Imaging System, Product Offered and Application
  • 3.8 Global Key Manufacturers of Nuclear Molecular Imaging System, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Nuclear Molecular Imaging System Sales by Type
    • 4.1.1 Global Nuclear Molecular Imaging System Historical Sales by Type (2018-2023)
    • 4.1.2 Global Nuclear Molecular Imaging System Forecasted Sales by Type (2024-2029)
    • 4.1.3 Global Nuclear Molecular Imaging System Sales Market Share by Type (2018-2029)
  • 4.2 Global Nuclear Molecular Imaging System Revenue by Type
    • 4.2.1 Global Nuclear Molecular Imaging System Historical Revenue by Type (2018-2023)
    • 4.2.2 Global Nuclear Molecular Imaging System Forecasted Revenue by Type (2024-2029)
    • 4.2.3 Global Nuclear Molecular Imaging System Revenue Market Share by Type (2018-2029)
  • 4.3 Global Nuclear Molecular Imaging System Price by Type
    • 4.3.1 Global Nuclear Molecular Imaging System Price by Type (2018-2023)
    • 4.3.2 Global Nuclear Molecular Imaging System Price Forecast by Type (2024-2029)

5 Market Size by Application

  • 5.1 Global Nuclear Molecular Imaging System Sales by Application
    • 5.1.1 Global Nuclear Molecular Imaging System Historical Sales by Application (2018-2023)
    • 5.1.2 Global Nuclear Molecular Imaging System Forecasted Sales by Application (2024-2029)
    • 5.1.3 Global Nuclear Molecular Imaging System Sales Market Share by Application (2018-2029)
  • 5.2 Global Nuclear Molecular Imaging System Revenue by Application
    • 5.2.1 Global Nuclear Molecular Imaging System Historical Revenue by Application (2018-2023)
    • 5.2.2 Global Nuclear Molecular Imaging System Forecasted Revenue by Application (2024-2029)
    • 5.2.3 Global Nuclear Molecular Imaging System Revenue Market Share by Application (2018-2029)
  • 5.3 Global Nuclear Molecular Imaging System Price by Application
    • 5.3.1 Global Nuclear Molecular Imaging System Price by Application (2018-2023)
    • 5.3.2 Global Nuclear Molecular Imaging System Price Forecast by Application (2024-2029)

6 US & Canada

  • 6.1 US & Canada Nuclear Molecular Imaging System Market Size by Type
    • 6.1.1 US & Canada Nuclear Molecular Imaging System Sales by Type (2018-2029)
    • 6.1.2 US & Canada Nuclear Molecular Imaging System Revenue by Type (2018-2029)
  • 6.2 US & Canada Nuclear Molecular Imaging System Market Size by Application
    • 6.2.1 US & Canada Nuclear Molecular Imaging System Sales by Application (2018-2029)
    • 6.2.2 US & Canada Nuclear Molecular Imaging System Revenue by Application (2018-2029)
  • 6.3 US & Canada Nuclear Molecular Imaging System Market Size by Country
    • 6.3.1 US & Canada Nuclear Molecular Imaging System Revenue by Country: 2018 VS 2022 VS 2029
    • 6.3.2 US & Canada Nuclear Molecular Imaging System Sales by Country (2018-2029)
    • 6.3.3 US & Canada Nuclear Molecular Imaging System Revenue by Country (2018-2029)
    • 6.3.4 US
    • 6.3.5 Canada

7 Europe

  • 7.1 Europe Nuclear Molecular Imaging System Market Size by Type
    • 7.1.1 Europe Nuclear Molecular Imaging System Sales by Type (2018-2029)
    • 7.1.2 Europe Nuclear Molecular Imaging System Revenue by Type (2018-2029)
  • 7.2 Europe Nuclear Molecular Imaging System Market Size by Application
    • 7.2.1 Europe Nuclear Molecular Imaging System Sales by Application (2018-2029)
    • 7.2.2 Europe Nuclear Molecular Imaging System Revenue by Application (2018-2029)
  • 7.3 Europe Nuclear Molecular Imaging System Market Size by Country
    • 7.3.1 Europe Nuclear Molecular Imaging System Revenue by Country: 2018 VS 2022 VS 2029
    • 7.3.2 Europe Nuclear Molecular Imaging System Sales by Country (2018-2029)
    • 7.3.3 Europe Nuclear Molecular Imaging System Revenue by Country (2018-2029)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Russia

8 China

  • 8.1 China Nuclear Molecular Imaging System Market Size
    • 8.1.1 China Nuclear Molecular Imaging System Sales (2018-2029)
    • 8.1.2 China Nuclear Molecular Imaging System Revenue (2018-2029)
  • 8.2 China Nuclear Molecular Imaging System Market Size by Application
    • 8.2.1 China Nuclear Molecular Imaging System Sales by Application (2018-2029)
    • 8.2.2 China Nuclear Molecular Imaging System Revenue by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Nuclear Molecular Imaging System Market Size by Type
    • 9.1.1 Asia Nuclear Molecular Imaging System Sales by Type (2018-2029)
    • 9.1.2 Asia Nuclear Molecular Imaging System Revenue by Type (2018-2029)
  • 9.2 Asia Nuclear Molecular Imaging System Market Size by Application
    • 9.2.1 Asia Nuclear Molecular Imaging System Sales by Application (2018-2029)
    • 9.2.2 Asia Nuclear Molecular Imaging System Revenue by Application (2018-2029)
  • 9.3 Asia Nuclear Molecular Imaging System Sales by Region
    • 9.3.1 Asia Nuclear Molecular Imaging System Revenue by Region: 2018 VS 2022 VS 2029
    • 9.3.2 Asia Nuclear Molecular Imaging System Revenue by Region (2018-2029)
    • 9.3.3 Asia Nuclear Molecular Imaging System Sales by Region (2018-2029)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 China Taiwan
    • 9.3.7 Southeast Asia
    • 9.3.8 India

10 Middle East, Africa and Latin America

  • 10.1 Middle East, Africa and Latin America Nuclear Molecular Imaging System Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America Nuclear Molecular Imaging System Sales by Type (2018-2029)
    • 10.1.2 Middle East, Africa and Latin America Nuclear Molecular Imaging System Revenue by Type (2018-2029)
  • 10.2 Middle East, Africa and Latin America Nuclear Molecular Imaging System Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America Nuclear Molecular Imaging System Sales by Application (2018-2029)
    • 10.2.2 Middle East, Africa and Latin America Nuclear Molecular Imaging System Revenue by Application (2018-2029)
  • 10.3 Middle East, Africa and Latin America Nuclear Molecular Imaging System Sales by Country
    • 10.3.1 Middle East, Africa and Latin America Nuclear Molecular Imaging System Revenue by Country: 2018 VS 2022 VS 2029
    • 10.3.2 Middle East, Africa and Latin America Nuclear Molecular Imaging System Revenue by Country (2018-2029)
    • 10.3.3 Middle East, Africa and Latin America Nuclear Molecular Imaging System Sales by Country (2018-2029)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Turkey
    • 10.3.7 Israel
    • 10.3.8 GCC Countries

11 Company Profiles

  • 11.1 Bruker
    • 11.1.1 Bruker Company Information
    • 11.1.2 Bruker Overview
    • 11.1.3 Bruker Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.1.4 Bruker Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Bruker Recent Developments
  • 11.2 GE Healthcare
    • 11.2.1 GE Healthcare Company Information
    • 11.2.2 GE Healthcare Overview
    • 11.2.3 GE Healthcare Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.2.4 GE Healthcare Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 GE Healthcare Recent Developments
  • 11.3 Siemens Healthcare
    • 11.3.1 Siemens Healthcare Company Information
    • 11.3.2 Siemens Healthcare Overview
    • 11.3.3 Siemens Healthcare Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.3.4 Siemens Healthcare Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Siemens Healthcare Recent Developments
  • 11.4 Philips Healthcare
    • 11.4.1 Philips Healthcare Company Information
    • 11.4.2 Philips Healthcare Overview
    • 11.4.3 Philips Healthcare Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.4.4 Philips Healthcare Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Philips Healthcare Recent Developments
  • 11.5 Canon Medical Systems
    • 11.5.1 Canon Medical Systems Company Information
    • 11.5.2 Canon Medical Systems Overview
    • 11.5.3 Canon Medical Systems Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.5.4 Canon Medical Systems Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Canon Medical Systems Recent Developments
  • 11.6 Hitachi Medical
    • 11.6.1 Hitachi Medical Company Information
    • 11.6.2 Hitachi Medical Overview
    • 11.6.3 Hitachi Medical Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.6.4 Hitachi Medical Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Hitachi Medical Recent Developments
  • 11.7 Digirad Corporation
    • 11.7.1 Digirad Corporation Company Information
    • 11.7.2 Digirad Corporation Overview
    • 11.7.3 Digirad Corporation Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.7.4 Digirad Corporation Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Digirad Corporation Recent Developments
  • 11.8 DDD-Diagnostics A/S
    • 11.8.1 DDD-Diagnostics A/S Company Information
    • 11.8.2 DDD-Diagnostics A/S Overview
    • 11.8.3 DDD-Diagnostics A/S Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.8.4 DDD-Diagnostics A/S Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 DDD-Diagnostics A/S Recent Developments
  • 11.9 Neusoft Medical Systems Co. Ltd.
    • 11.9.1 Neusoft Medical Systems Co. Ltd. Company Information
    • 11.9.2 Neusoft Medical Systems Co. Ltd. Overview
    • 11.9.3 Neusoft Medical Systems Co. Ltd. Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.9.4 Neusoft Medical Systems Co. Ltd. Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 Neusoft Medical Systems Co. Ltd. Recent Developments
  • 11.10 Mediso Medical Imaging Systems, Ltd.
    • 11.10.1 Mediso Medical Imaging Systems, Ltd. Company Information
    • 11.10.2 Mediso Medical Imaging Systems, Ltd. Overview
    • 11.10.3 Mediso Medical Imaging Systems, Ltd. Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.10.4 Mediso Medical Imaging Systems, Ltd. Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Mediso Medical Imaging Systems, Ltd. Recent Developments
  • 11.11 SurgicEye GmbH
    • 11.11.1 SurgicEye GmbH Company Information
    • 11.11.2 SurgicEye GmbH Overview
    • 11.11.3 SurgicEye GmbH Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.11.4 SurgicEye GmbH Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.11.5 SurgicEye GmbH Recent Developments
  • 11.12 CMR Naviscan Corporation
    • 11.12.1 CMR Naviscan Corporation Company Information
    • 11.12.2 CMR Naviscan Corporation Overview
    • 11.12.3 CMR Naviscan Corporation Nuclear Molecular Imaging System Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.12.4 CMR Naviscan Corporation Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.12.5 CMR Naviscan Corporation Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Nuclear Molecular Imaging System Industry Chain Analysis
  • 12.2 Nuclear Molecular Imaging System Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Nuclear Molecular Imaging System Production Mode & Process
  • 12.4 Nuclear Molecular Imaging System Sales and Marketing
    • 12.4.1 Nuclear Molecular Imaging System Sales Channels
    • 12.4.2 Nuclear Molecular Imaging System Distributors
  • 12.5 Nuclear Molecular Imaging System Customers

13 Market Dynamics

  • 13.1 Nuclear Molecular Imaging System Industry Trends
  • 13.2 Nuclear Molecular Imaging System Market Drivers
  • 13.3 Nuclear Molecular Imaging System Market Challenges
  • 13.4 Nuclear Molecular Imaging System Market Restraints

14 Key Findings in The Global Nuclear Molecular Imaging System Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer

List of Tables

  • Table 1. Global Nuclear Molecular Imaging System Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 2. Major Manufacturers of Positron Emission Tomography
  • Table 3. Major Manufacturers of Single-photon Emission Computed Tomography
  • Table 4. Major Manufacturers of Planar Scintigraphy Systems
  • Table 5. Global Nuclear Molecular Imaging System Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 6. Global Nuclear Molecular Imaging System Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 7. Global Nuclear Molecular Imaging System Revenue by Region (2018-2023) & (US$ Million)
  • Table 8. Global Nuclear Molecular Imaging System Revenue by Region (2024-2029) & (US$ Million)
  • Table 9. Global Nuclear Molecular Imaging System Revenue Market Share by Region (2018-2023)
  • Table 10. Global Nuclear Molecular Imaging System Revenue Market Share by Region (2024-2029)
  • Table 11. Global Nuclear Molecular Imaging System Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 12. Global Nuclear Molecular Imaging System Sales by Region (2018-2023) & (K Units)
  • Table 13. Global Nuclear Molecular Imaging System Sales by Region (2024-2029) & (K Units)
  • Table 14. Global Nuclear Molecular Imaging System Sales Market Share by Region (2018-2023)
  • Table 15. Global Nuclear Molecular Imaging System Sales Market Share by Region (2024-2029)
  • Table 16. Global Nuclear Molecular Imaging System Sales by Manufacturers (2018-2023) & (K Units)
  • Table 17. Global Nuclear Molecular Imaging System Sales Share by Manufacturers (2018-2023)
  • Table 18. Global Nuclear Molecular Imaging System Revenue by Manufacturers (2018-2023) & (US$ Million)
  • Table 19. Global Nuclear Molecular Imaging System Revenue Share by Manufacturers (2018-2023)
  • Table 20. Global Key Players of Nuclear Molecular Imaging System, Industry Ranking, 2021 VS 2022 VS 2023
  • Table 21. Nuclear Molecular Imaging System Price by Manufacturers 2018-2023 (US$/Unit)
  • Table 22. Global Nuclear Molecular Imaging System Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 23. Global Nuclear Molecular Imaging System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Molecular Imaging System as of 2022)
  • Table 24. Global Key Manufacturers of Nuclear Molecular Imaging System, Manufacturing Base Distribution and Headquarters
  • Table 25. Global Key Manufacturers of Nuclear Molecular Imaging System, Product Offered and Application
  • Table 26. Global Key Manufacturers of Nuclear Molecular Imaging System, Date of Enter into This Industry
  • Table 27. Mergers & Acquisitions, Expansion Plans
  • Table 28. Global Nuclear Molecular Imaging System Sales by Type (2018-2023) & (K Units)
  • Table 29. Global Nuclear Molecular Imaging System Sales by Type (2024-2029) & (K Units)
  • Table 30. Global Nuclear Molecular Imaging System Sales Share by Type (2018-2023)
  • Table 31. Global Nuclear Molecular Imaging System Sales Share by Type (2024-2029)
  • Table 32. Global Nuclear Molecular Imaging System Revenue by Type (2018-2023) & (US$ Million)
  • Table 33. Global Nuclear Molecular Imaging System Revenue by Type (2024-2029) & (US$ Million)
  • Table 34. Global Nuclear Molecular Imaging System Revenue Share by Type (2018-2023)
  • Table 35. Global Nuclear Molecular Imaging System Revenue Share by Type (2024-2029)
  • Table 36. Nuclear Molecular Imaging System Price by Type (2018-2023) & (US$/Unit)
  • Table 37. Global Nuclear Molecular Imaging System Price Forecast by Type (2024-2029) & (US$/Unit)
  • Table 38. Global Nuclear Molecular Imaging System Sales by Application (2018-2023) & (K Units)
  • Table 39. Global Nuclear Molecular Imaging System Sales by Application (2024-2029) & (K Units)
  • Table 40. Global Nuclear Molecular Imaging System Sales Share by Application (2018-2023)
  • Table 41. Global Nuclear Molecular Imaging System Sales Share by Application (2024-2029)
  • Table 42. Global Nuclear Molecular Imaging System Revenue by Application (2018-2023) & (US$ Million)
  • Table 43. Global Nuclear Molecular Imaging System Revenue by Application (2024-2029) & (US$ Million)
  • Table 44. Global Nuclear Molecular Imaging System Revenue Share by Application (2018-2023)
  • Table 45. Global Nuclear Molecular Imaging System Revenue Share by Application (2024-2029)
  • Table 46. Nuclear Molecular Imaging System Price by Application (2018-2023) & (US$/Unit)
  • Table 47. Global Nuclear Molecular Imaging System Price Forecast by Application (2024-2029) & (US$/Unit)
  • Table 48. US & Canada Nuclear Molecular Imaging System Sales by Type (2018-2023) & (K Units)
  • Table 49. US & Canada Nuclear Molecular Imaging System Sales by Type (2024-2029) & (K Units)
  • Table 50. US & Canada Nuclear Molecular Imaging System Revenue by Type (2018-2023) & (US$ Million)
  • Table 51. US & Canada Nuclear Molecular Imaging System Revenue by Type (2024-2029) & (US$ Million)
  • Table 52. US & Canada Nuclear Molecular Imaging System Sales by Application (2018-2023) & (K Units)
  • Table 53. US & Canada Nuclear Molecular Imaging System Sales by Application (2024-2029) & (K Units)
  • Table 54. US & Canada Nuclear Molecular Imaging System Revenue by Application (2018-2023) & (US$ Million)
  • Table 55. US & Canada Nuclear Molecular Imaging System Revenue by Application (2024-2029) & (US$ Million)
  • Table 56. US & Canada Nuclear Molecular Imaging System Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 57. US & Canada Nuclear Molecular Imaging System Revenue by Country (2018-2023) & (US$ Million)
  • Table 58. US & Canada Nuclear Molecular Imaging System Revenue by Country (2024-2029) & (US$ Million)
  • Table 59. US & Canada Nuclear Molecular Imaging System Sales by Country (2018-2023) & (K Units)
  • Table 60. US & Canada Nuclear Molecular Imaging System Sales by Country (2024-2029) & (K Units)
  • Table 61. Europe Nuclear Molecular Imaging System Sales by Type (2018-2023) & (K Units)
  • Table 62. Europe Nuclear Molecular Imaging System Sales by Type (2024-2029) & (K Units)
  • Table 63. Europe Nuclear Molecular Imaging System Revenue by Type (2018-2023) & (US$ Million)
  • Table 64. Europe Nuclear Molecular Imaging System Revenue by Type (2024-2029) & (US$ Million)
  • Table 65. Europe Nuclear Molecular Imaging System Sales by Application (2018-2023) & (K Units)
  • Table 66. Europe Nuclear Molecular Imaging System Sales by Application (2024-2029) & (K Units)
  • Table 67. Europe Nuclear Molecular Imaging System Revenue by Application (2018-2023) & (US$ Million)
  • Table 68. Europe Nuclear Molecular Imaging System Revenue by Application (2024-2029) & (US$ Million)
  • Table 69. Europe Nuclear Molecular Imaging System Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 70. Europe Nuclear Molecular Imaging System Revenue by Country (2018-2023) & (US$ Million)
  • Table 71. Europe Nuclear Molecular Imaging System Revenue by Country (2024-2029) & (US$ Million)
  • Table 72. Europe Nuclear Molecular Imaging System Sales by Country (2018-2023) & (K Units)
  • Table 73. Europe Nuclear Molecular Imaging System Sales by Country (2024-2029) & (K Units)
  • Table 74. China Nuclear Molecular Imaging System Sales by Type (2018-2023) & (K Units)
  • Table 75. China Nuclear Molecular Imaging System Sales by Type (2024-2029) & (K Units)
  • Table 76. China Nuclear Molecular Imaging System Revenue by Type (2018-2023) & (US$ Million)
  • Table 77. China Nuclear Molecular Imaging System Revenue by Type (2024-2029) & (US$ Million)
  • Table 78. China Nuclear Molecular Imaging System Sales by Application (2018-2023) & (K Units)
  • Table 79. China Nuclear Molecular Imaging System Sales by Application (2024-2029) & (K Units)
  • Table 80. China Nuclear Molecular Imaging System Revenue by Application (2018-2023) & (US$ Million)
  • Table 81. China Nuclear Molecular Imaging System Revenue by Application (2024-2029) & (US$ Million)
  • Table 82. Asia Nuclear Molecular Imaging System Sales by Type (2018-2023) & (K Units)
  • Table 83. Asia Nuclear Molecular Imaging System Sales by Type (2024-2029) & (K Units)
  • Table 84. Asia Nuclear Molecular Imaging System Revenue by Type (2018-2023) & (US$ Million)
  • Table 85. Asia Nuclear Molecular Imaging System Revenue by Type (2024-2029) & (US$ Million)
  • Table 86. Asia Nuclear Molecular Imaging System Sales by Application (2018-2023) & (K Units)
  • Table 87. Asia Nuclear Molecular Imaging System Sales by Application (2024-2029) & (K Units)
  • Table 88. Asia Nuclear Molecular Imaging System Revenue by Application (2018-2023) & (US$ Million)
  • Table 89. Asia Nuclear Molecular Imaging System Revenue by Application (2024-2029) & (US$ Million)
  • Table 90. Asia Nuclear Molecular Imaging System Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 91. Asia Nuclear Molecular Imaging System Revenue by Region (2018-2023) & (US$ Million)
  • Table 92. Asia Nuclear Molecular Imaging System Revenue by Region (2024-2029) & (US$ Million)
  • Table 93. Asia Nuclear Molecular Imaging System Sales by Region (2018-2023) & (K Units)
  • Table 94. Asia Nuclear Molecular Imaging System Sales by Region (2024-2029) & (K Units)
  • Table 95. Middle East, Africa and Latin America Nuclear Molecular Imaging System Sales by Type (2018-2023) & (K Units)
  • Table 96. Middle East, Africa and Latin America Nuclear Molecular Imaging System Sales by Type (2024-2029) & (K Units)
  • Table 97. Middle East, Africa and Latin America Nuclear Molecular Imaging System Revenue by Type (2018-2023) & (US$ Million)
  • Table 98. Middle East, Africa and Latin America Nuclear Molecular Imaging System Revenue by Type (2024-2029) & (US$ Million)
  • Table 99. Middle East, Africa and Latin America Nuclear Molecular Imaging System Sales by Application (2018-2023) & (K Units)
  • Table 100. Middle East, Africa and Latin America Nuclear Molecular Imaging System Sales by Application (2024-2029) & (K Units)
  • Table 101. Middle East, Africa and Latin America Nuclear Molecular Imaging System Revenue by Application (2018-2023) & (US$ Million)
  • Table 102. Middle East, Africa and Latin America Nuclear Molecular Imaging System Revenue by Application (2024-2029) & (US$ Million)
  • Table 103. Middle East, Africa and Latin America Nuclear Molecular Imaging System Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 104. Middle East, Africa and Latin America Nuclear Molecular Imaging System Revenue by Country (2018-2023) & (US$ Million)
  • Table 105. Middle East, Africa and Latin America Nuclear Molecular Imaging System Revenue by Country (2024-2029) & (US$ Million)
  • Table 106. Middle East, Africa and Latin America Nuclear Molecular Imaging System Sales by Country (2018-2023) & (K Units)
  • Table 107. Middle East, Africa and Latin America Nuclear Molecular Imaging System Sales by Country (2024-2029) & (K Units)
  • Table 108. Bruker Company Information
  • Table 109. Bruker Description and Major Businesses
  • Table 110. Bruker Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 111. Bruker Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 112. Bruker Recent Developments
  • Table 113. GE Healthcare Company Information
  • Table 114. GE Healthcare Description and Major Businesses
  • Table 115. GE Healthcare Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 116. GE Healthcare Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 117. GE Healthcare Recent Developments
  • Table 118. Siemens Healthcare Company Information
  • Table 119. Siemens Healthcare Description and Major Businesses
  • Table 120. Siemens Healthcare Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 121. Siemens Healthcare Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 122. Siemens Healthcare Recent Developments
  • Table 123. Philips Healthcare Company Information
  • Table 124. Philips Healthcare Description and Major Businesses
  • Table 125. Philips Healthcare Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 126. Philips Healthcare Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 127. Philips Healthcare Recent Developments
  • Table 128. Canon Medical Systems Company Information
  • Table 129. Canon Medical Systems Description and Major Businesses
  • Table 130. Canon Medical Systems Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 131. Canon Medical Systems Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 132. Canon Medical Systems Recent Developments
  • Table 133. Hitachi Medical Company Information
  • Table 134. Hitachi Medical Description and Major Businesses
  • Table 135. Hitachi Medical Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 136. Hitachi Medical Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 137. Hitachi Medical Recent Developments
  • Table 138. Digirad Corporation Company Information
  • Table 139. Digirad Corporation Description and Major Businesses
  • Table 140. Digirad Corporation Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 141. Digirad Corporation Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 142. Digirad Corporation Recent Developments
  • Table 143. DDD-Diagnostics A/S Company Information
  • Table 144. DDD-Diagnostics A/S Description and Major Businesses
  • Table 145. DDD-Diagnostics A/S Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 146. DDD-Diagnostics A/S Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 147. DDD-Diagnostics A/S Recent Developments
  • Table 148. Neusoft Medical Systems Co. Ltd. Company Information
  • Table 149. Neusoft Medical Systems Co. Ltd. Description and Major Businesses
  • Table 150. Neusoft Medical Systems Co. Ltd. Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 151. Neusoft Medical Systems Co. Ltd. Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 152. Neusoft Medical Systems Co. Ltd. Recent Developments
  • Table 153. Mediso Medical Imaging Systems, Ltd. Company Information
  • Table 154. Mediso Medical Imaging Systems, Ltd. Description and Major Businesses
  • Table 155. Mediso Medical Imaging Systems, Ltd. Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 156. Mediso Medical Imaging Systems, Ltd. Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 157. Mediso Medical Imaging Systems, Ltd. Recent Developments
  • Table 158. SurgicEye GmbH Company Information
  • Table 159. SurgicEye GmbH Description and Major Businesses
  • Table 160. SurgicEye GmbH Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 161. SurgicEye GmbH Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 162. SurgicEye GmbH Recent Developments
  • Table 163. CMR Naviscan Corporation Company Information
  • Table 164. CMR Naviscan Corporation Description and Major Businesses
  • Table 165. CMR Naviscan Corporation Nuclear Molecular Imaging System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 166. CMR Naviscan Corporation Nuclear Molecular Imaging System Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 167. CMR Naviscan Corporation Recent Developments
  • Table 168. Key Raw Materials Lists
  • Table 169. Raw Materials Key Suppliers Lists
  • Table 170. Nuclear Molecular Imaging System Distributors List
  • Table 171. Nuclear Molecular Imaging System Customers List
  • Table 172. Nuclear Molecular Imaging System Market Trends
  • Table 173. Nuclear Molecular Imaging System Market Drivers
  • Table 174. Nuclear Molecular Imaging System Market Challenges
  • Table 175. Nuclear Molecular Imaging System Market Restraints
  • Table 176. Research Programs/Design for This Report
  • Table 177. Key Data Information from Secondary Sources
  • Table 178. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Nuclear Molecular Imaging System Product Picture
  • Figure 2. Global Nuclear Molecular Imaging System Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 3. Global Nuclear Molecular Imaging System Market Share by Type in 2022 & 2029
  • Figure 4. Positron Emission Tomography Product Picture
  • Figure 5. Single-photon Emission Computed Tomography Product Picture
  • Figure 6. Planar Scintigraphy Systems Product Picture
  • Figure 7. Global Nuclear Molecular Imaging System Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 8. Global Nuclear Molecular Imaging System Market Share by Application in 2022 & 2029
  • Figure 9. Oncology
  • Figure 10. Cardiology
  • Figure 11. Neurology
  • Figure 12. Others
  • Figure 13. Nuclear Molecular Imaging System Report Years Considered
  • Figure 14. Global Nuclear Molecular Imaging System Revenue, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 15. Global Nuclear Molecular Imaging System Revenue 2018-2029 (US$ Million)
  • Figure 16. Global Nuclear Molecular Imaging System Revenue Market Share by Region in Percentage: 2022 Versus 2029
  • Figure 17. Global Nuclear Molecular Imaging System Revenue Market Share by Region (2018-2029)
  • Figure 18. Global Nuclear Molecular Imaging System Sales 2018-2029 ((K Units)
  • Figure 19. Global Nuclear Molecular Imaging System Sales Market Share by Region (2018-2029)
  • Figure 20. US & Canada Nuclear Molecular Imaging System Sales YoY (2018-2029) & (K Units)
  • Figure 21. US & Canada Nuclear Molecular Imaging System Revenue YoY (2018-2029) & (US$ Million)
  • Figure 22. Europe Nuclear Molecular Imaging System Sales YoY (2018-2029) & (K Units)
  • Figure 23. Europe Nuclear Molecular Imaging System Revenue YoY (2018-2029) & (US$ Million)
  • Figure 24. China Nuclear Molecular Imaging System Sales YoY (2018-2029) & (K Units)
  • Figure 25. China Nuclear Molecular Imaging System Revenue YoY (2018-2029) & (US$ Million)
  • Figure 26. Asia (excluding China) Nuclear Molecular Imaging System Sales YoY (2018-2029) & (K Units)
  • Figure 27. Asia (excluding China) Nuclear Molecular Imaging System Revenue YoY (2018-2029) & (US$ Million)
  • Figure 28. Middle East, Africa and Latin America Nuclear Molecular Imaging System Sales YoY (2018-2029) & (K Units)
  • Figure 29. Middle East, Africa and Latin America Nuclear Molecular Imaging System Revenue YoY (2018-2029) & (US$ Million)
  • Figure 30. The Nuclear Molecular Imaging System Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
  • Figure 31. The Top 5 and 10 Largest Manufacturers of Nuclear Molecular Imaging System in the World: Market Share by Nuclear Molecular Imaging System Revenue in 2022
  • Figure 32. Global Nuclear Molecular Imaging System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
  • Figure 33. Global Nuclear Molecular Imaging System Sales Market Share by Type (2018-2029)
  • Figure 34. Global Nuclear Molecular Imaging System Revenue Market Share by Type (2018-2029)
  • Figure 35. Global Nuclear Molecular Imaging System Sales Market Share by Application (2018-2029)
  • Figure 36. Global Nuclear Molecular Imaging System Revenue Market Share by Application (2018-2029)
  • Figure 37. US & Canada Nuclear Molecular Imaging System Sales Market Share by Type (2018-2029)
  • Figure 38. US & Canada Nuclear Molecular Imaging System Revenue Market Share by Type (2018-2029)
  • Figure 39. US & Canada Nuclear Molecular Imaging System Sales Market Share by Application (2018-2029)
  • Figure 40. US & Canada Nuclear Molecular Imaging System Revenue Market Share by Application (2018-2029)
  • Figure 41. US & Canada Nuclear Molecular Imaging System Revenue Share by Country (2018-2029)
  • Figure 42. US & Canada Nuclear Molecular Imaging System Sales Share by Country (2018-2029)
  • Figure 43. U.S. Nuclear Molecular Imaging System Revenue (2018-2029) & (US$ Million)
  • Figure 44. Canada Nuclear Molecular Imaging System Revenue (2018-2029) & (US$ Million)
  • Figure 45. Europe Nuclear Molecular Imaging System Sales Market Share by Type (2018-2029)
  • Figure 46. Europe Nuclear Molecular Imaging System Revenue Market Share by Type (2018-2029)
  • Figure 47. Europe Nuclear Molecular Imaging System Sales Market Share by Application (2018-2029)
  • Figure 48. Europe Nuclear Molecular Imaging System Revenue Market Share by Application (2018-2029)
  • Figure 49. Europe Nuclear Molecular Imaging System Revenue Share by Country (2018-2029)
  • Figure 50. Europe Nuclear Molecular Imaging System Sales Share by Country (2018-2029)
  • Figure 51. Germany Nuclear Molecular Imaging System Revenue (2018-2029) & (US$ Million)
  • Figure 52. France Nuclear Molecular Imaging System Revenue (2018-2029) & (US$ Million)
  • Figure 53. U.K. Nuclear Molecular Imaging System Revenue (2018-2029) & (US$ Million)
  • Figure 54. Italy Nuclear Molecular Imaging System Revenue (2018-2029) & (US$ Million)
  • Figure 55. Russia Nuclear Molecular Imaging System Revenue (2018-2029) & (US$ Million)
  • Figure 56. China Nuclear Molecular Imaging System Sales Market Share by Type (2018-2029)
  • Figure 57. China Nuclear Molecular Imaging System Revenue Market Share by Type (2018-2029)
  • Figure 58. China Nuclear Molecular Imaging System Sales Market Share by Application (2018-2029)
  • Figure 59. China Nuclear Molecular Imaging System Revenue Market Share by Application (2018-2029)
  • Figure 60. Asia Nuclear Molecular Imaging System Sales Market Share by Type (2018-2029)
  • Figure 61. Asia Nuclear Molecular Imaging System Revenue Market Share by Type (2018-2029)
  • Figure 62. Asia Nuclear Molecular Imaging System Sales Market Share by Application (2018-2029)
  • Figure 63. Asia Nuclear Molecular Imaging System Revenue Market Share by Application (2018-2029)
  • Figure 64. Asia Nuclear Molecular Imaging System Revenue Share by Region (2018-2029)
  • Figure 65. Asia Nuclear Molecular Imaging System Sales Share by Region (2018-2029)
  • Figure 66. Japan Nuclear Molecular Imaging System Revenue (2018-2029) & (US$ Million)
  • Figure 67. South Korea Nuclear Molecular Imaging System Revenue (2018-2029) & (US$ Million)
  • Figure 68. China Taiwan Nuclear Molecular Imaging System Revenue (2018-2029) & (US$ Million)
  • Figure 69. Southeast Asia Nuclear Molecular Imaging System Revenue (2018-2029) & (US$ Million)
  • Figure 70. India Nuclear Molecular Imaging System Revenue (2018-2029) & (US$ Million)
  • Figure 71. Middle East, Africa and Latin America Nuclear Molecular Imaging System Sales Market Share by Type (2018-2029)
  • Figure 72. Middle East, Africa and Latin America Nuclear Molecular Imaging System Revenue Market Share by Type (2018-2029)
  • Figure 73. Middle East, Africa and Latin America Nuclear Molecular Imaging System Sales Market Share by Application (2018-2029)
  • Figure 74. Middle East, Africa and Latin America Nuclear Molecular Imaging System Revenue Market Share by Application (2018-2029)
  • Figure 75. Middle East, Africa and Latin America Nuclear Molecular Imaging System Revenue Share by Country (2018-2029)
  • Figure 76. Middle East, Africa and Latin America Nuclear Molecular Imaging System Sales Share by Country (2018-2029)
  • Figure 77. Brazil Nuclear Molecular Imaging System Revenue (2018-2029) & (US$ Million)
  • Figure 78. Mexico Nuclear Molecular Imaging System Revenue (2018-2029) & (US$ Million)
  • Figure 79. Turkey Nuclear Molecular Imaging System Revenue (2018-2029) & (US$ Million)
  • Figure 80. Israel Nuclear Molecular Imaging System Revenue (2018-2029) & (US$ Million)
  • Figure 81. GCC Countries Nuclear Molecular Imaging System Revenue (2018-2029) & (US$ Million)
  • Figure 82. Nuclear Molecular Imaging System Value Chain
  • Figure 83. Nuclear Molecular Imaging System Production Process
  • Figure 84. Channels of Distribution
  • Figure 85. Distributors Profiles
  • Figure 86. Bottom-up and Top-down Approaches for This Report
  • Figure 87. Data Triangulation
  • Figure 88. Key Executives Interviewed
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!